Jazz Pharmaceuticals JAZZ US — PP&E (Net)
Discontinued — last reported Q4 '18
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 25, 2020, on SEC EDGAR. View the filing →
Questions, answered.
- What does US — PP&E (net) mean?
- The total value of the company's physical assets in the United States after accounting for wear and tear.
- How do you interpret US — PP&E (net)?
- An increase typically indicates ongoing capital investment in US-based manufacturing or research infrastructure, while a decrease may suggest asset divestiture, high depreciation rates, or a shift toward outsourcing production.
- How does US — PP&E (net) compare across companies?
- Peers in the biopharmaceutical industry typically report this as part of their regional asset base, with variations driven by whether the company utilizes internal manufacturing or relies on contract manufacturing organizations (CMOs).